{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:16:05Z","timestamp":1792880165321,"version":"4.5.0"},"reference-count":62,"publisher":"Japanese Society of Hypertension","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2006]]},"DOI":"10.1291\/hypres.29.49","type":"journal-article","created":{"date-parts":[[2006,6,6]],"date-time":"2006-06-06T05:54:38Z","timestamp":1149573278000},"page":"49-56","source":"Crossref","is-referenced-by-count":49,"title":["Amlodipine-Induced Reduction of Oxidative Stress in the Brain Is Associated with Sympatho-Inhibitory Effects in Stroke-Prone Spontaneously Hypertensive Rats"],"prefix":"10.1291","volume":"29","author":[{"given":"Yoshitaka","family":"HIROOKA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikuni","family":"KIMURA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatsugu","family":"NOZOE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoji","family":"SAGARA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"ITO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"SUNAGAWA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"119","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.23.2981"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16451-9"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Furberg CD, Psaty BM, Meyer JV: Nifedipine: dose-related increase in mortality in patients with coronary heart disease. <i>Circulation<\/i> 1995; <b>92<\/b>: 1325-1331.","DOI":"10.1161\/01.CIR.92.5.1326"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03306-7"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Opie LH, Yasuf S, K&uuml;ber W: Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: a critical analysis based on 100 studies. <i>Prog Cardiovasc Dis<\/i> 2000; <b>43<\/b>: 171-196.","DOI":"10.1053\/pcad.2000.7010"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(97)00158-7"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00250.2003"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Gerzanich V, Ivanova S, van der Heijden MS, Zhou H, Simard JM: Trans-cellular proliferating cell nuclear antigen gene activation in cerebral vascular smooth muscle by endothelial oxidative injury <i>in vivo<\/i>. <i>Arterioscler Thromb Vasc Biol<\/i> 2003; <b>23<\/b>: 2048-2054.","DOI":"10.1161\/01.ATV.0000094962.07514.BC"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Blezer ELA, Nicolay K, Goldschmeding R, Koomans HA, Joles JA: Reduction of cerebral injury in stroke-prone spontaneously hypertensive rats by amlodipine. <i>Eur J Pharmacol<\/i> 2002; <b>444<\/b>: 75-81.","DOI":"10.1016\/S0014-2999(02)01609-6"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Pitt B, Byington RP, Furberg CD, <i>et al<\/i>, PREVENT Investigators: Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. <i>Circulation<\/i> 2000; <b>102<\/b>: 1503-1510.","DOI":"10.1161\/01.CIR.102.13.1503"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Zhang X, Hintze TH: Amlodipine releases nitric oxide from canine coronary microvessels: an unexpected mechanism of action of a calcium channel-blocking agent. <i>Circulation<\/i> 1998; <b>97<\/b>: 576-580.","DOI":"10.1161\/01.CIR.97.6.576"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Zhou M-S, Jaimes EA, Raij L: Inhibition of oxidative stress and improvement of endothelial function by amlodipine in angiotensin II-infused rats. <i>Am J Hypertens<\/i> 2004; <b>17<\/b>: 167-171.","DOI":"10.1016\/j.amjhyper.2003.09.007"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.1998.0867"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.27.271"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000013264.41234.24"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200018120-00023"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199816010-00016"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.28.351"},{"issue":"5111","key":"19","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1126\/science.8388125","volume":"260","year":"1993","ISSN":"https:\/\/id.crossref.org\/issn\/0036-8075","issn-type":"print"},{"issue":"4784","key":"20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1126\/science.2432656","volume":"235","year":"1987","ISSN":"https:\/\/id.crossref.org\/issn\/0036-8075","issn-type":"print"},{"issue":"2","key":"21","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1161\/01.HYP.35.2.631","volume":"35","author":"MURZENOK P P","year":"2000","ISSN":"https:\/\/id.crossref.org\/issn\/0194-911X","issn-type":"print"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200308000-00001"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kishi T, Hirooka Y, Kimura Y, Ito K, Shimokawa H, Takeshita A: Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. <i>Circulation<\/i> 2004; <b>109<\/b>: 2357-2362.","DOI":"10.1161\/01.CIR.0000128695.49900.12"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000138070.47616.9d"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Ganafa AA, Walton M, Eatman D, Abukhalaf IK, Bayorh MA: Amlodipine attenuates oxidative stress-induced hypertension. <i>Am J Hypertens<\/i> 2004; <b>17<\/b>: 743-748.","DOI":"10.1016\/j.amjhyper.2004.05.013"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199816090-00017"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Taddei S, Virdis A, Ghiadoni L, <i>et al<\/i>: Calcium antagonist treatment by lercanidipine prevents hyperpolarization in essential hypertension. <i>Hypertension<\/i> 2003; <b>41<\/b>: 950-955.","DOI":"10.1161\/01.HYP.0000063361.70525.3C"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Yavuz DG, Tugler S, Ko&ccedil;ak H, Ozener C, Akoglu E, Akalin S: Angiotensin converting enzyme inhibition and calcium channel blockage improves cyclosporine induced glucose intolerance in rats. <i>Transplant Proc<\/i> 2004; <b>36<\/b>: 171-174.","DOI":"10.1016\/j.transproceed.2003.11.038"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1159\/000082598"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.28.689"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Kishi T, Hirooka Y, Mukai Y, Shimokawa H, Takeshita A: Atorvastatin causes depressor and sympatho-inhibitory effects with upregulation of nitric oxide synthases in stroke-prone spontaneously hypertensive rats. <i>J Hypertens<\/i> 2003; <b>21<\/b>: 379-386.","DOI":"10.1097\/00004872-200302000-00030"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Ide T, Tsutsui H, Kinugawa S, <i>et al<\/i>: Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. <i>Circ Res<\/i> 1999; <b>85<\/b>: 357-363.","DOI":"10.1161\/01.RES.85.4.357"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Ide T, Tsutsui H, Kinugawa S, <i>et al<\/i>: Direct evidence for increased hydroxyradicals originating from superoxide in the failing myocardium. <i>Circ Res<\/i> 2000; <b>86<\/b>: 152-157.","DOI":"10.1161\/01.RES.86.2.152"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Ito K, Hirooka Y, Kishi T, <i>et al<\/i>: Rho\/Rho-kinase pathway in the brainstem contributes to hypertension caused by chronic nitric oxide synthase inhibition. <i>Hypertension<\/i> 2004; <b>43<\/b>: 156-162.","DOI":"10.1161\/01.HYP.0000114602.82140.a4"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Kimura Y, Hirooka Y, Sagara Y, <i>et al<\/i>: Overexpression of inducible nitric oxide synthase in rostral ventrolateral medulla causes hypertension and sympathoexcitation <i>via<\/i> an increase in oxidative stress. <i>Circ Res<\/i> 2005; <b>96<\/b>: 252-260.","DOI":"10.1161\/01.RES.0000152965.75127.9d"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Sugawara H, Tobise K, Kikuchi K: Antioxidant effects of calcium antagonists on rat myocardial membrane lipid peroxidation. <i>Hypertens Res<\/i> 1996; <b>19<\/b>: 223-228.","DOI":"10.1291\/hypres.19.223"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(00)02954-1"},{"key":"38","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M201924200"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Tseng W-P, Lin-Shiau S-Y: Neuronal death signaling by &beta;-bungarotoxin through the activation of the <i>N<\/i>-methyl-<small>D<\/small>-aspartate (NMDA) receptor and L-type calcium channel. <i>Biochem Pharmacol<\/i> 2003; <b>65<\/b>: 131-142.","DOI":"10.1016\/S0006-2952(02)01477-6"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Wang R-M, Zhang Q-G, Zhang G-Y: Activation of ERK5 is mediated by <i>N<\/i>-methyl-<small>D<\/small>-aspartate receptor and L-type voltage-gated calcium channel <i>via<\/i> Src involving oxidative stress after cerebral ischemia in rat hippocampus. <i>Neurosci Lett<\/i> 2004; <b>357<\/b>: 13-16.","DOI":"10.1016\/j.neulet.2003.11.061"},{"key":"41","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000021924.02006.BA"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Napoli C, Salomone S, Godfraind T, <i>et al<\/i>: 1,4-Dihydropyridine calcium channel blockers inhibit plasma and LDL oxidation and formation of oxidation-specific epitopes in the arterial wall and prolong survival in stroke-prone spontaneously hypertensive rats. <i>Stroke<\/i> 1999; <b>30<\/b>: 1907-1915.","DOI":"10.1161\/01.STR.30.9.1907"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Hou X, Gobeil F, Marrache AM, <i>et al<\/i>: Increased platelet-activating factor-induced periventricular brain microvascular constriction associated with immaturity. <i>Am J Physiol Regul Integr Comp Physiol<\/i> 2003; <b>284<\/b>: 928-935.","DOI":"10.1152\/ajpregu.00633.2002"},{"key":"44","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(92)90102-D"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Ohtsuki T, Matsumoto M, Suzuki K, Taniguchi N, Kamada T: Mitochondrial lipid peroxidation and superoxide dismutase in rat hypertensive target organs. <i>Am J Physiol<\/i> 1995; <b>268<\/b>: H1418-H1421.","DOI":"10.1152\/ajpheart.1995.268.4.H1418"},{"key":"46","doi-asserted-by":"publisher","DOI":"10.1161\/hy0202.102701"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Dampney RAL: Functional organization of central pathways regulating the cardiovascular system. <i>Physiol Rev<\/i> 1994; <b>74<\/b>: 323-364.","DOI":"10.1152\/physrev.1994.74.2.323"},{"key":"48","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200209000-00002"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Higuchi S, Takeshita A, Ito N, Imaizumi T, Matsuguchi H, Nakamura M: Arterial pressure and heart rate responses to calcium channel blockers administered in the brainstem in rats. <i>Circ Res<\/i> 1985; <b>57<\/b>: 244-251.","DOI":"10.1161\/01.RES.57.2.244"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Zanzinger J: Mechanisms of action of nitric oxide in the brain stem. <i>Auton Neurosci<\/i> 2002; <b>98<\/b>: 24-27.","DOI":"10.1016\/S1566-0702(02)00025-5"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Patel KP, Li Y-F, Hirooka Y: Role of nitric oxide in central sympathetic outflow. <i>Exp Biol Med<\/i> 2001; <b>226<\/b>: 814-824.","DOI":"10.1177\/153537020122600902"},{"key":"52","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.26.325"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Berkels R, Taubert D, Bartels H, Bretenbach T, Klaus W, Roesen R: Amlodipine increases endothelial nitric oxide by dual mechanisms. <i>Pharmacology<\/i> 2004; <b>70<\/b>: 39-45.","DOI":"10.1159\/000074241"},{"key":"54","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.27.877"},{"issue":"6","key":"55","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1161\/01.HYP.33.6.1353","volume":"33","author":"KERR S","year":"1999","ISSN":"https:\/\/id.crossref.org\/issn\/0194-911X","issn-type":"print"},{"key":"56","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(99)00623-0"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Wilson SK: Role of oxygen-derived free radicals in acute angiotensin II-induced hypertensive vascular disease in the rat. <i>Circ Res<\/i> 1990; <b>66<\/b>: 722-734.","DOI":"10.1161\/01.RES.66.3.722"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Zhang XM, Ellis EF: Superoxide dismutase reduces permeability and edema induced by hypertension in rats. <i>Am J Physiol<\/i> 1990; <b>259<\/b>: H497-H503.","DOI":"10.1152\/ajpheart.1990.259.2.H497"},{"issue":"6 Pt 1","key":"59","first-page":"854","volume":"26","year":"1995","ISSN":"https:\/\/id.crossref.org\/issn\/0194-911X","issn-type":"print"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Spence JD: Preventing dementia by treating hypertension and preventing stroke. <i>Hypertension<\/i> 2004; <b>44<\/b>: 20-21.","DOI":"10.1161\/01.HYP.0000132374.90924.2a"},{"issue":"6","key":"61","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/sj.bjp.0701226","volume":"121","year":"1997","ISSN":"https:\/\/id.crossref.org\/issn\/0007-1188","issn-type":"print"},{"key":"62","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(99)00237-X"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T05:08:53Z","timestamp":1555650533000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nature.com\/doifinder\/10.1291\/hypres.29.49"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1291\/hypres.29.49","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006]]}}}